2021 annual financial data

Coherus Oncology, Inc. 2021 Net margin

Coherus Oncology, Inc. 2021 net margin with verified reported values.

Direct answer

Net margin was -87.92%.

Operating income was -263,858,000 USD and net income was -287,100,000 USD.
Operating cash flow was -37,432,000 USD.

Get free Coherus Oncology, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
326,551,000 USD
Operating income
-263,858,000 USD
Net income
-287,100,000 USD
Operating cash flow
-37,432,000 USD